constipation%20in%20adults%20-%20chronic%20functional
CONSTIPATION IN ADULTS - CHRONIC FUNCTIONAL
Constipation is an unsatisfactory defecation distinguished by difficult stool passage, infrequent stools or both.
Difficult stool passage may include straining, feeling of difficulty in passing stool, incomplete evacuation, lumpy/hard stools, prolonged time to defecate, need for manual maneuver to pass stool, abdominal discomfort and feeling of anorectal blockade.
Chronic constipation is considered when symptoms of constipation have existed ≥3 months.
Symptoms of chronic constipation may be due to dysfunction of intestinal motility, visceral sensitivity, anorectal musculature or the enteric nervous system.
Drug Information
Agiolax
plantago ovata husks + plantago seeds + sennosides

Indication: Traditionally used for constipation.

Indication: Symptomatic treatment of abdominal pain & cramps, bowel disturbances & intestinal discomfort related t...

Indication: Symptomatic treatment of chronic constipation in adults whom laxatives fail to provide adequate relief.

Indication: Acute spasm, as in renal or biliary chronic, in radiology for differential diagnosis of obstruction. Reduction...

Indication: Constipation. Prep of diagnostic procedures, in pre- & post-op treatment & in conditions which require...

Forlax
macrogol 4000

Indication: Symptomatic treatment of constipation in adults & childn ≥8 yr.

Indication: Spasmodic pain, oesophageal spasm, cholecystitis, choledocholithiasis, dysuria & pollakisuria, spasmodic d...

Indication: Relief of constipation eg, constipation in pregnancy & maintenance of regularity. Bowel function managemen...

Indication: Relief of occasional constipation.

1  /  4
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Elvira Manzano, 14 Aug 2018
A new study reinforces the gut-brain connection in Alzheimer’s disease (AD), untangling the complex interplay between gut and brain health that could potentially lead to new therapies targeted at manipulating the gut microbiome to treat AD.
Roshini Claire Anthony, 6 days ago

Reducing the dose of regorafenib did little to affect the overall tolerability of the drug in patients with metastatic colorectal cancer (mCRC), according to the phase II REARRANGE* trial presented at ESMO GI 2019.